Recent investigations have underscored the emerging significance of germline pathogenic variants in HRR-related genes, notably BRCA1, ATM, and PALB2, as predisposing factors for CRC, particularly early-onset cases [41–43]. This evidence concerns the gene PALB2 and colorectal carcinoma.